Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Gynecol Endocrinol ; 33(12): 923-927, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28452240

ABSTRACT

This study hypothesizes that oral rosuvastatin, oral dienogest and intraperitoneal bevacizumab might improve endometriosis in randomly selected female Wistar albino rats with surgically endometriotic implants. Thirty female Wistar albino rats with surgically endometriotic implants were randomized into three treatment groups: oral rosuvastatin (20 mg kg/day; oral rosuvastatin group 1; n = 10), oral progesterone (dienogest group 2; n = 10) and intraperitoneal bevacizumab (2.5 mg/kg of single intraperitoneal injection of bevacizumab; bevacizumab group 3; n = 10), for 10 days. Post-treatment variables were compared. The oral rosuvastatin group showed higher reduction for the glandular epithelium and uterine vessels of histopathological scores values than the oral progesterone group (both, p < 0.017, respectively). The median glandular epithelium and uterine vessels and histopathological scores values did not show a statistically significant difference between group 1 and group 3 (p > 0.017). Endometrial thickness values and uterine volume values were more significantly reduced in the oral rosuvastatin group than the oral progesterone group (both, p < 0.017, respectively). Moreover, endometrial thickness and uterine volume values were not different in groups wecompared with group 3 (p > 0.017). In conclusion, oral rosuvastatin and intraperitoneal injection of bevacizumab may cause more significant regression of surgically endometriotic implants in rats than oral progesterone medications.


Subject(s)
Angiogenesis Inhibitors/therapeutic use , Bevacizumab/therapeutic use , Endometriosis/drug therapy , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Nandrolone/analogs & derivatives , Rosuvastatin Calcium/therapeutic use , Animals , Drug Evaluation, Preclinical , Female , Nandrolone/therapeutic use , Rats, Wistar
2.
Asian Pac J Cancer Prev ; 16(7): 2671-4, 2015.
Article in English | MEDLINE | ID: mdl-25854344

ABSTRACT

Thyroid cancer is the most prevalent endocrine cancer and is evident in nearly 5% of thyroid nodules. The correlation between mean platelet volume (MPV) and many other cancer types has been investigated previously. However, the correlation between papillary thyroid carcinoma (PTC) and MPV has not yet been studied in detail. The aim of this study was to examine whether MPV would be a useful inflammatory marker to differentiate PTC patients from cases of benign goiter and healthy controls. Preoperative MPV levels in patients with PTC were found to be significantly higher when compared with benign goiter patients and healthy controls ((respectively, 8.05 femtoliter (fl), 7.57 fl, 7.36 fl, p=0.001). After surgical treatment of PTC patients, a significant decrease in MPV levels was seen (8.05 fl versus 7.60 fl, p=0.005). ROC analysis suggested 7.81 as the cut-off value for MPV (AUC=0.729, sensitivity 60%, specificity 80%). In conclusion, maybe changes in MPV levels can be used as an easily available biomarker for monitoring the risk of PTC in patients with thyroid nodules, enabling early diagnosis of PTC.


Subject(s)
Biomarkers, Tumor/blood , Carcinoma/blood , Carcinoma/diagnosis , Mean Platelet Volume , Thyroid Neoplasms/blood , Thyroid Neoplasms/diagnosis , Adult , Aged , Carcinoma/pathology , Carcinoma, Papillary , Early Detection of Cancer/methods , Female , Humans , Male , Middle Aged , ROC Curve , Retrospective Studies , Thyroid Cancer, Papillary , Thyroid Gland/pathology , Thyroid Neoplasms/pathology , Thyroid Nodule/pathology
3.
Eur J Gastroenterol Hepatol ; 26(7): 725-32, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24901818

ABSTRACT

OBJECTIVE: Both ulcerative colitis and Crohn's disease are forms of inflammatory bowel disease (IBD), which is characterized by chronic, progressive inflammation of the gastrointestinal tract. Recent studies have shed new light on the importance of inflammation in the pathogenesis of arterial stiffness. AIM: This study aimed to evaluate the relationship between pulse wave velocity (PWV) measurement and biochemical parameters in inactive and active IBD patients without cardiovascular risk factors and perform a comparison with the control group. MATERIALS AND METHODS: We enrolled 102 IBD patients without cardiovascular risk factors and 74 matched controls, and evaluated each patient in active and inactive disease periods. All patients completed a standard questionnaire form and we assessed various laboratory parameters. We carried out vascular measurements using a Mobil-O-Graph 24-h pulse wave analysis monitor, an automatic oscillometric device. RESULTS: Although cardiovascular risk factors, such as total cholesterol and low-density lipoprotein cholesterol, were significantly lower (P<0.05) in IBD patients than the controls, 24 h, day and night PWV values, erythrocyte sedimentation rate, C-reactive protein, insulin, homeostasis model assessment of insulin resistance, and homocysteine were higher in patients with active and inactive IBD than the controls (P<0.05). Multiple linear regression analysis showed that PWV was correlated positively with age and duration of IBD. CONCLUSION: This study showed increased PWV, homocysteine, erythrocyte sedimentation rate, C-reactive protein, insulin, and homeostasis model assessment of insulin resistance in patients with active and inactive IBD and provides evidence of the potential contribution of inflammation and inflammation-related factors toward arterial stiffening independent from conventional cardiovascular risk factors.


Subject(s)
Blood Flow Velocity/physiology , Colitis, Ulcerative/physiopathology , Crohn Disease/physiopathology , Insulin Resistance/physiology , Insulin/blood , Pulsatile Flow/physiology , Adult , Blood Sedimentation , Colitis, Ulcerative/epidemiology , Colitis, Ulcerative/metabolism , Crohn Disease/epidemiology , Crohn Disease/metabolism , Female , Homeostasis/immunology , Homocysteine/blood , Humans , Inflammation/epidemiology , Inflammation/metabolism , Inflammation/physiopathology , Linear Models , Male , Middle Aged , Risk Factors , Statistics, Nonparametric , Vascular Stiffness/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...